Fact CheckerSign in

NCT05151952Recruiting

Proton Therapy Medical Registry

Source: ClinicalTrials.gov · Last updated 9 Dec 2021 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Clínica Universidad de Navarra Proton Therapy Unit is establishing a registry to capture the full radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity and quality of life outcomes. The objectives are parameters prescribed and to have all patients treated at the proton therapy unit to be included in the registry to enable future analysis of treatment outcomes to assist in understanding, which patients can benefit from the use of protons.

Status (registry)
Recruiting
Study type
Observational
Enrollment
6000 (estimated)
First submitted
11 Nov 2021
Start date
1 Apr 2020
Primary completion date
1 Apr 2030
Lead sponsor
Clinica Universidad de Navarra, Universidad de Navarra
NCT number
NCT05151952

What you commit to

  • Study type: Observational
  • Planned participants: 6000
  • From 1 Apr 2020 to the primary completion date, 1 Apr 2030
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Any other than what is supplied in the inclusion criteria

Who the study is looking for

  • All patients treated at the proton center

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Clinica Universidad de Navarra
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Clínica Universidad de navarra
Coordinator of this site? Confirm its status
PamplonaSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.